MLchartDataset catalogue

CI-1033

Term · Oncology and biomedicine · MLC-T-ONC-001758

A substance being studied in the treatment of some types of cancer. CI-1033 blocks the action of proteins called epidermal growth factor receptors, and may cause cancer cells to die. It is a type of tyrosine kinase inhibitor. Also called canertinib dihydrochloride.

Table 1. Record
IdentifierMLC-T-ONC-001758
FieldOncology and biomedicine
Expansionscanertinib dihydrochloride
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-001758",
  "term": "CI-1033",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of some types of cancer. CI-1033 blocks the action of proteins called epidermal growth factor receptors, and may cause cancer cells to die. It is a type of tyrosine kinase inhibitor. Also called canertinib dihydrochloride.",
  "expansions": [
    "canertinib dihydrochloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ci-1033/"
}

Record 4,835 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.